MYX mayne pharma group limited

2HFY23 to $131.5m revenue growth

  1. 1,066 Posts.
    lightbulb Created with Sketch. 92
    Delivered revenue growth in 2HFY23 across all segments to $131.5m (1HFY23: $52.1m). 2HFY23 gross profit increased
    to $66.6m (1HFY23: $16.9m) and positive direct contribution of $0.9m (1HFY23: negative direct contribution of $42.7m)
    ✓ Generated positive operating free cash flow of $14.1m in 2HFY23


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.06
Change
-0.015(0.30%)
Mkt cap ! $410.2M
Open High Low Value Volume
$5.05 $5.08 $5.02 $385.8K 76.40K

Buyers (Bids)

No. Vol. Price($)
1 68 $5.36
 

Sellers (Offers)

Price($) Vol. No.
$4.76 73 2
View Market Depth
Last trade - 15.59pm 07/08/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.